Final Program

TUESDAY • MAY 17 315
2:35 Infection and Exacerbations of Asthma
Y.J. Huang, MD, Ann Arbor, MI
3:00 Respiratory Infection and COPD
J.R. Hurst, MBChB, PhD, London, United Kingdom
3:25 Microbial Dysbiosis and Exacerbations of Bronchiectasis
J.D. Chalmers, MBChB, PhD, Dundee, United Kingdom
3:50 The Role of Infection in the Progression of ILD
H.R. Collard, MD, San Francisco, CA
C83
There will be a 5-minute discussion after each talk.
CLINICAL • TRANSLATIONAL
CLINICAL TOPICS IN PULMONARY MEDICINE
CME Credits Available: 2.0
NEW CONCEPTS REGARDING LUNG TRANSPLANT
ALLOGRAFT DYSFUNCTION
Assemblies on Clinical Problems; Allergy, Immunology and Inflammation
2:15 p.m. - 4:15 p.m. MOSCONE CENTER
Room 134 (North Building, Lower Level)
Target Audience
Physicians and surgeons, nurses, respiratory therapists, pharmacists,
trainees, industry.
Objectives
At the conclusion of this session, the participant will be able to:
• gain an understanding of changes in the definitions of PDG, AMR, and
CLAD;
• improve diagnostic approaches to lung allograft dysfunction that include
HLA monitoring and pathology assessment;
• develop new strategies for diagnosing PGD, AMR, and CLAD.
Lung allograft dysfunction definitions and diagnoses have evolved over time.
Speakers will address reassessment of primary graft dysfunction definition and
grading, diagnosis of antibody mediated rejection of the lung allograft, the pros
and cons of HLA antibody monitoring, and recognition of new subtypes of
chronic lung allograft dysfunction.
Chairing: D.J. Levine, MD, San Antonio, TX
2:15 Redefining Primary Graft Dysfunction
J.D. Christie, MD, MSCE, Philadelphia, PA
2:39 Definition and Diagnosis of Lung Allograft Antibody Mediated
Rejection
R.D. Yusen, MD, MPH, St. Louis, MO
3:03 HLA Antibody Monitoring in Lung Transplantation
D.B. Tyan, PhD, Palo Alto, CA
3:27 Chronic Lung Allograft Dysfunction (CLAD) Classification
Update
A.R. Glanville, MBBS, MD, Sydney, Australia
3:51 Pathology of Pulmonary Allograft Dysfunction
G.J. Berry, MD, Palo Alto, CA
There will be a 5-minute discussion after each talk.
C84
BEHAVIORAL • CLINICAL
CRITICAL CARE TRACK
CME Credits Available: 2.0
THE NEW ICU RECOVERY TOOLKIT: 5 HAMMERS
LOOKING FOR THE RIGHT NAIL
Assemblies on Critical Care; Behavioral Science and Health Services
Research; Clinical Problems
2:15 p.m. - 4:15 p.m. MOSCONE CENTER
Room 3000/3002/3004 (West Building, Level 3)
Target Audience
Clinicians working in the ICU or dealing with patients in its aftermath.
Objectives
At the conclusion of this session, the participant will be able to:
• more appropriately evaluate proposals for what post-ICU interventions their
program should find;
• recommend resources to their patients on ICU discharge more selectively
and with increased effectiveness;
• understand the strengths and limitations of existing data on ICU recovery
interventions.
While we all know that problems are common after the ICU, nobody really
knows what to do to make those problems better. Some people are worried
enough that they seem ready to jump on any potential solution. Five
approaches seem to garner the most excitement. In this session, we step back
from the individual solutions to ask emerging leaders in the field: Why should
this approach work? What are the data so far? (And why might they have been
negative despite the approach still being hopeful?) How do we pick the right
patient and system for that intervention?
Chairing: T.J. Iwashyna, MD, PhD, Ann Arbor, MI
C. Hodgson, PT, PhD, Melbourne, Australia
N. Pinto, MD, Chicago, IL
2:15 Fix the Brain
J.C. Jackson, PsyD, Nashville, TN
2:35 Move the Body
C. Hodgson, PT, PhD, Melbourne, Australia
2:55 Recruit the General Practitioners
J. Gensichen, MD, MSc, MPH, Jena, Germany
3:15 Do it Ourselves (with a Post-ICU Clinic)
E. Wilcox, MD, MPH, Toronto, Canada
3:35 Help Survivors Help Each Other
M.E. Mikkelsen, MD, Philadelphia, PA
3:55 Not if, but Which: Selecting the Right Follow-Up for the Right
Patient
H.C. Prescott, MD, MA, Ann Arbor, MI
TUESDAY AFTERNOON
ATS 2016 • San Francisco